Autolus Therapeutics to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Autolus Therapeutics (Nasdaq: AUTL) will participate in two investor conferences in April 2026. The CEO, Dr. Christian Itin, will present at the 25th Annual Needham Virtual Healthcare Conference on April 13, 2028 at 10:15am EDT / 3:15pm BST. A webcast and 90-day replay will be available on the company's Events page. Management will also host investor meetings at the Van Lanschot Kempen Life Sciences Conference in Amsterdam on April 16, 2026.

News Market Reaction – AUTL

-2.16%

7 alerts

-2.16% Session close to close

+2.0% Peak in 9 hr 5 min

$399.21M Market Cap

0.6x Rel. Volume

In the Apr 7 session, AUTL declined 2.16%, reflecting a moderate negative market reaction. Argus tracked a peak move of +2.0% during that session. Our momentum scanner triggered 7 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

LONDON and GAITHERSBURG, Md., April 07, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announced that the Company will participate in two upcoming investor conferences.

25th Annual Needham Virtual Healthcare Conference
Date and time: April 13, 2028; 10:15am EDT / 3:15pm BST
Presenter: Chief Executive Officer Dr. Christian Itin

A webcast of the presentation will be available on the “Events” page in the “Investor Relations & Media” section of the Company’s website at https://www.autolus.com/investor-relations-media/events/. A replay of the webcast will be archived on the Company’s website for 90 days following the presentation.

Van Lanschot Kempen Life Sciences Conference
Management to host investor meetings
Date: April 16, 2026
Location: Amsterdam

About Autolus Therapeutics plc
Autolus Therapeutics plc (Nasdaq: AUTL) is a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation T cell therapies and candidates for the treatment of cancer and autoimmune disease. Using a broad suite of proprietary and modular T cell programming technologies, Autolus is engineering precisely targeted and controlled T cell therapies that are designed to better recognize target cells, break down their defense mechanisms and eliminate these cells. Autolus has a marketed therapy, AUCATZYL^®, and a pipeline of product candidates in development for the treatment of hematological malignancies, solid tumors and autoimmune diseases. For more information, please visit www.autolus.com. 

Contact:

Amanda Cray
+1 617-967-0207
a.cray@autolus.com

FAQ

When will Autolus (AUTL) present at the Needham Virtual Healthcare Conference?

Autolus will present on April 13, 2028 at 10:15am EDT / 3:15pm BST. According to the company, CEO Dr. Christian Itin will deliver the presentation and a live webcast will be accessible via the Events page.

How can investors watch the AUTL webcast for the April presentation?

Investors can watch the live webcast on the company's Events page and access a replay archived for 90 days. According to the company, the webcast will be posted in the Investor Relations & Media Events section.

What is Autolus management doing at the Van Lanschot Kempen Life Sciences Conference?

Management will host investor meetings in Amsterdam on April 16, 2026. According to the company, these sessions are scheduled as part of the conference's investor-program activities.

Who will present for Autolus at the Needham conference and what is their title?

CEO Dr. Christian Itin will present at the Needham Virtual Healthcare Conference. According to the company, Dr. Itin will represent Autolus during the scheduled presentation and webcast.

How long will the Autolus webcast replay be available after the April presentation?

The replay will be archived on the company's website for 90 days following the presentation. According to the company, investors can access the archived webcast on the Events page during that period.